Finance

Lists
532983:BOM
RPG Life Sciences Ltd
₹2 818,00
-1,45%
(-41,35) 1D
13 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 532983...
Open
₹2 850,20
High
₹2 850,25
Low
₹2 759,20
Mkt. cap
46,33 mjd
Avg. vol.
1,69 k
Volume
641,00
Dividend
0,85%
Quarterly dividend
₹6,00
Ex-dividend date
09 Jul. 2026
P/E ratio
38,96
52-wk high
₹3 130,50
52-wk low
₹1 731,25
EPS
₹72,34
Shares outstanding
16,54 m
No. of employees
1 k
Open
₹2 850,20
High
₹2 850,25
Low
₹2 759,20
Mkt. cap
46,33 mjd
Avg. vol.
1,69 k
Volume
641,00
Dividend
0,85%
Quarterly dividend
₹6,00
Ex-dividend date
09 Jul. 2026
P/E ratio
38,96
52-wk high
₹3 130,50
52-wk low
₹1 731,25
EPS
₹72,34
Shares outstanding
16,54 m
No. of employees
1 k
News stories
From web sources and news partners
Profile
RPG Life Sciences is an Indian pharmaceutical company. Formerly known as Searle Ltd, RPG Life Sciences is part of RPG Enterprises. It has its corporate office in RPG House in Worli, Mumbai. Its three major activities are the manufacturing and marketing of bulk drugs, also known as active pharmaceutical ingredients; pharmaceutical formulation; and fermentation and biotechnology. RPGLS is present in the domestic as well as the international market. It exports its products primarily to Europe, Latin America, Australia and South East Asian countries. Wikipedia
About RPG Life Sciences Ltd
CEO-
Employees1,37 k
Founded1993
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,82 mjd
1,80 mjd
1,77 mjd
1,96 mjd
Cost of goods sold
665,80 m
649,00 m
661,00 m
681,50 m
Cost of revenue
665,80 m
649,00 m
661,00 m
681,50 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
361,60 m
353,20 m
570,90 m
377,60 m
Operating expense
812,90 m
807,50 m
835,00 m
901,50 m
Total operating expenses
1,48 mjd
1,46 mjd
1,50 mjd
1,58 mjd
Operating income
338,10 m
343,80 m
273,30 m
373,90 m
Other non operating income
45,40 m
34,10 m
-101,90 m
47,00 m
EBT including unusual items
494,50 m
291,20 m
402,00 m
414,60 m
EBT excluding unusual items
382,30 m
375,40 m
277,30 m
414,60 m
Income tax expense
126,00 m
69,90 m
103,00 m
107,00 m
Effective tax rate
25,48%
24,00%
25,62%
25,81%
Other operating expenses
399,10 m
400,50 m
206,70 m
464,90 m
Net income
368,50 m
221,30 m
299,00 m
307,60 m
Net profit margin
20,28%
12,29%
16,90%
15,72%
Earnings per share
-
-
-
-
Interest and investment income
-
-
96,70 m
-
Interest expense
-1,20 m
-2,50 m
-3,90 m
-6,30 m
Net interest expenses
-1,20 m
-2,50 m
92,80 m
-6,30 m
Depreciation and amortization charges
52,20 m
53,80 m
57,40 m
59,00 m
EBITDA
389,90 m
395,75 m
325,80 m
426,40 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme